OBJECTIVE: The low number of postnatal endothelial progenitor cells (EPC) in the circulation limits their therapeutic application in cardiovascular medicine. Processed lipoaspirate (PLA) cells differentiate into osteoid, adipose, muscle, and cartilaginous cells. This study examines the potential of PLA cells as a source of EPCs. METHODS: PLA cells obtained from human lipoaspirates were cultured for 1 week in serum-depleted medium to form three-dimensional cell clusters (3DCC). The phenotype of 3DCC-derived cells was assessed by immunofluorescence staining and FACS analysis. RESULTS: Flow cytometry showed that 45+/-5% of cells derived from the 3DCC expressed Flk-1, a marker of early EPC, whilst only 4+/-0.5% of freshly isolated PLA were Flk-1+. The proportion of Flk-1+ cells increased to 98+/-2% during culture in hematopoietic stem cell medium. When cultured in an endothelial cell (EC)-specific medium, Flk-1+ cells also expressed Ve-cadherin, von Willebrand's factor (vW), and a lectin receptor, and took up low-density lipoprotein. Incorporation into an endothelial cell tubular network confirmed their functional activity. CONCLUSION: This report describes the first isolation and culture of Flk-1+ cells from human adipose tissue. The feasibility of the extraction and culture of these cells in increased numbers suggests that such autologous cells will be useful for applications ranging from basic research to cell-based therapies.
OBJECTIVE: The low number of postnatal endothelial progenitor cells (EPC) in the circulation limits their therapeutic application in cardiovascular medicine. Processed lipoaspirate (PLA) cells differentiate into osteoid, adipose, muscle, and cartilaginous cells. This study examines the potential of PLA cells as a source of EPCs. METHODS: PLA cells obtained from human lipoaspirates were cultured for 1 week in serum-depleted medium to form three-dimensional cell clusters (3DCC). The phenotype of 3DCC-derived cells was assessed by immunofluorescence staining and FACS analysis. RESULTS: Flow cytometry showed that 45+/-5% of cells derived from the 3DCC expressed Flk-1, a marker of early EPC, whilst only 4+/-0.5% of freshly isolated PLA were Flk-1+. The proportion of Flk-1+ cells increased to 98+/-2% during culture in hematopoietic stem cell medium. When cultured in an endothelial cell (EC)-specific medium, Flk-1+ cells also expressed Ve-cadherin, von Willebrand's factor (vW), and a lectin receptor, and took up low-density lipoprotein. Incorporation into an endothelial cell tubular network confirmed their functional activity. CONCLUSION: This report describes the first isolation and culture of Flk-1+ cells from human adipose tissue. The feasibility of the extraction and culture of these cells in increased numbers suggests that such autologous cells will be useful for applications ranging from basic research to cell-based therapies.
Authors: Jorge Paz Rodriguez; Michael P Murphy; Soonjun Hong; Marialaura Madrigal; Keith L March; Boris Minev; Robert J Harman; Chien-Shing Chen; Ruben Berrocal Timmons; Annette M Marleau; Neil H Riordan Journal: Int Arch Med Date: 2012-02-08
Authors: Isaac Perea-Gil; Juan J Uriarte; Cristina Prat-Vidal; Carolina Gálvez-Montón; Santiago Roura; Aida Llucià-Valldeperas; Carolina Soler-Botija; Ramon Farré; Daniel Navajas; Antoni Bayes-Genis Journal: Am J Transl Res Date: 2015-03-15 Impact factor: 4.060
Authors: Carolina Soler-Botija; Juli R Bagó; Aida Llucià-Valldeperas; Ana Vallés-Lluch; Cristina Castells-Sala; Cristina Martínez-Ramos; Teresa Fernández-Muiños; Juan Carlos Chachques; Manuel Monleón Pradas; Carlos E Semino; Antoni Bayes-Genis Journal: Am J Transl Res Date: 2014-05-15 Impact factor: 4.060
Authors: Cynthia Hamou; Matthew J Callaghan; Hariharan Thangarajah; Edwin Chang; Eric I Chang; Raymon H Grogan; Josemaria Paterno; Ivan N Vial; Leila Jazayeri; Geoffrey C Gurtner Journal: Plast Reconstr Surg Date: 2009-02 Impact factor: 4.730
Authors: Katja Schenke-Layland; Brian M Strem; Maria C Jordan; Michael T Deemedio; Marc H Hedrick; Kenneth P Roos; John K Fraser; W Robb Maclellan Journal: J Surg Res Date: 2008-04-10 Impact factor: 2.192